These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 38518535)
21. Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis. Stassen RC; Maas CCHM; van der Veldt AAM; Lo SN; Saw RPM; Varey AHR; Scolyer RA; Long GV; Thompson JF; Rutkowski P; Keilholz U; van Akkooi ACJ; Verhoef C; van Klaveren D; Grünhagen DJ Lancet Oncol; 2024 Apr; 25(4):509-517. PubMed ID: 38547894 [TBL] [Abstract][Full Text] [Related]
22. Using the Merlin assay for reducing sentinel lymph node biopsy complications in melanoma: a retrospective cohort study. Hieken TJ; Sadurní MB; Quattrocchi E; Kobic A; Sominidi-Damodaran S; Dwarkasing JT; Meerstein-Kessel L; Bridges AG; Meves A Int J Dermatol; 2022 Jul; 61(7):848-854. PubMed ID: 35100440 [TBL] [Abstract][Full Text] [Related]
23. Predictors of sentinel lymph node positivity in thin melanoma using the National Cancer Database. Conic RRZ; Ko J; Damiani G; Funchain P; Knackstedt T; Vij A; Vidimos A; Gastman BR J Am Acad Dermatol; 2019 Feb; 80(2):441-447. PubMed ID: 30240775 [TBL] [Abstract][Full Text] [Related]
24. Breslow thickness 2.0: Why gene expression profiling is a step toward better patient selection for sentinel lymph node biopsies. Sadurní MB; Meves A Mod Pathol; 2022 Nov; 35(11):1509-1514. PubMed ID: 35654998 [TBL] [Abstract][Full Text] [Related]
25. Cost evaluation of the Merlin assay for predicting melanoma sentinel lymph node biopsy metastasis. Thao V; Dholakia R; Moriarty JP; Borah BJ; Dwarkasing J; Meves A Int J Dermatol; 2023 Jan; 62(1):56-61. PubMed ID: 36440797 [TBL] [Abstract][Full Text] [Related]
26. Prospective validation of the prognostic 31-gene expression profiling test in primary cutaneous melanoma. Keller J; Schwartz TL; Lizalek JM; Chang ES; Patel AD; Hurley MY; Hsueh EC Cancer Med; 2019 May; 8(5):2205-2212. PubMed ID: 30950242 [TBL] [Abstract][Full Text] [Related]
27. Sentinel lymph node biopsy in acral melanoma: A Korean single-center experience with 107 patients (2006-2018). Sohng C; Sim HB; Kim JY; Lim Y; Han MH; Lee H; Ahn BC; Huh S; Lee SJ Asia Pac J Clin Oncol; 2021 Feb; 17(1):115-122. PubMed ID: 33079454 [TBL] [Abstract][Full Text] [Related]
28. Integration of a 31-Gene Expression Profile Into Clinical Decision-Making in the Treatment of Cutaneous Melanoma. Scott AM; Dale PS; Conforti A; Gibbs JN Am Surg; 2020 Nov; 86(11):1561-1564. PubMed ID: 32755379 [TBL] [Abstract][Full Text] [Related]
29. Cervical sentinel lymph node biopsy for melanomas of the head and neck and upper thorax. Wagner JD; Park HM; Coleman JJ; Love C; Hayes JT Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):313-21. PubMed ID: 10722003 [TBL] [Abstract][Full Text] [Related]
31. The Integrated i31-GEP Test Outperforms the MSKCC Nomogram at Predicting SLN Status in Melanoma Patients. Tassavor M; Martin BJ; Glazer AM Anticancer Res; 2023 Oct; 43(10):4511-4516. PubMed ID: 37772588 [TBL] [Abstract][Full Text] [Related]
32. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study. Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169 [TBL] [Abstract][Full Text] [Related]
33. Sentinel lymph node biopsy is a prognostic measure in pediatric melanoma. Kim J; Sun Z; Gulack BC; Adam MA; Mosca PJ; Rice HE; Tracy ET J Pediatr Surg; 2016 Jun; 51(6):986-90. PubMed ID: 27041229 [TBL] [Abstract][Full Text] [Related]
34. Identifying challenges to implementation of clinical practice guidelines for sentinel lymph node biopsy in patients with melanoma in Australia: protocol paper for a mixed methods study. Rapport F; Smith AL; Cust AE; Mann GJ; Watts CG; Gyorki DE; Henderson M; Hong AM; Kelly JW; Long GV; Mar VJ; Morton RL; Saw RP; Scolyer RA; Spillane AJ; Thompson JF; Braithwaite J BMJ Open; 2020 Feb; 10(2):e032636. PubMed ID: 32111612 [TBL] [Abstract][Full Text] [Related]
35. Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients. Zager JS; Gastman BR; Leachman S; Gonzalez RC; Fleming MD; Ferris LK; Ho J; Miller AR; Cook RW; Covington KR; Meldi-Plasseraud K; Middlebrook B; Kaminester LH; Greisinger A; Estrada SI; Pariser DM; Cranmer LD; Messina JL; Vetto JT; Wayne JD; Delman KA; Lawson DH; Gerami P BMC Cancer; 2018 Feb; 18(1):130. PubMed ID: 29402264 [TBL] [Abstract][Full Text] [Related]
36. Sentinel lymph node biopsy is unreliable in predicting melanoma mortality for both younger and older patients. Dixon AJ; Kyrgidis A; Steinman HK; Dixon JB; Sladden M; Garbe C; Lallas A; Zachary CB; Leiter-Stöppke U; Smith H; Nirenberg A; Zouboulis CC; Longo C; Argenziano G; Apalla Z; Popescu C; Tzellos T; Anderson S; Nanz L; Cleaver L; Thomas JM J Eur Acad Dermatol Venereol; 2024 Apr; 38(4):741-751. PubMed ID: 38168748 [TBL] [Abstract][Full Text] [Related]
37. Use of Lymph Node Ultrasound Prior to Sentinel Lymph Node Biopsy in 384 Patients with Melanoma: A Cost-Effectiveness Analysis. Olmedo D; Brotons-Seguí M; Del Toro C; González M; Requena C; Traves V; Pla A; Bolumar I; Moreno-Ramírez D; Nagore E Actas Dermosifiliogr; 2017 Dec; 108(10):931-938. PubMed ID: 28801012 [TBL] [Abstract][Full Text] [Related]
38. Li N; Zhou X; Zhu H; Wang F; Guo R; Zhang Y; Song Y; Zhai S; Xie Q; Liu J; Li Z; Yang Z Ann Nucl Med; 2023 Mar; 37(3):189-197. PubMed ID: 36586034 [TBL] [Abstract][Full Text] [Related]
39. Performance of Gene Expression Profile Tests for Prognosis in Patients With Localized Cutaneous Melanoma: A Systematic Review and Meta-analysis. Marchetti MA; Coit DG; Dusza SW; Yu A; McLean L; Hu Y; Nanda JK; Matsoukas K; Mancebo SE; Bartlett EK JAMA Dermatol; 2020 Sep; 156(9):953-962. PubMed ID: 32745161 [TBL] [Abstract][Full Text] [Related]